Werewolf Therapeutics HOWL Q1 2026 Earnings NarrowerthanExpected Loss Highlights Operational Discipline IMO Q1 2026 Earnings EPS Misses Estimates as Earnings Decline 1955 Below Consensus DRCT Q1 2026 Earnings NarrowerThanExpected Loss but Stock Declines Amid Revenue Uncertainty FOA Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency Textron Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction Murphy USA Inc MUSA Q1 2026 Earnings Earnings Surge Past Estimates Stock Slips Marginally